吐き気・嘔吐治療の世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9103793）

◆英語タイトル：Global Nausea And Vomiting Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9103793
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、吐き気・嘔吐治療の世界市場について調べ、まとめました。種類別セグメントは、セロトニン受容体拮抗薬、ニューロキニンNK1受容体拮抗薬、その他、セロトニン受容体拮抗薬は、2018年に61％の最大の市場シェアを持っていました。等、用途別セグメントは、CINV、PONV、動揺病、妊娠、その他等に区分しました。吐き気・嘔吐治療の世界市場概観、企業動向、企業別吐き気・嘔吐治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・吐き気・嘔吐治療の市場概観
・吐き気・嘔吐治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・吐き気・嘔吐治療の企業別販売動向、市場シェア、市場集中度、競争動向
・吐き気・嘔吐治療の世界市場規模
・吐き気・嘔吐治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・吐き気・嘔吐治療のアメリカ市場規模推移
・吐き気・嘔吐治療のカナダ市場規模推移
・吐き気・嘔吐治療のメキシコ市場規模推移
・吐き気・嘔吐治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・吐き気・嘔吐治療のドイツ市場規模推移
・吐き気・嘔吐治療のイギリス市場規模推移
・吐き気・嘔吐治療のロシア市場規模推移
・吐き気・嘔吐治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・吐き気・嘔吐治療の日本市場規模推移
・吐き気・嘔吐治療の中国市場規模推移
・吐き気・嘔吐治療の韓国市場規模推移
・吐き気・嘔吐治療のインド市場規模推移
・吐き気・嘔吐治療の東南アジア市場規模推移
・吐き気・嘔吐治療の南米市場分析（ブラジル、アルゼンチン等）
・吐き気・嘔吐治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・吐き気・嘔吐治療の種類別分析/販売量、売上、市場シェア（セロトニン受容体拮抗薬、ニューロキニンNK1受容体拮抗薬、その他、セロトニン受容体拮抗薬は、2018年に61％の最大の市場シェアを持っていました。）
・吐き気・嘔吐治療の用途別分析/市場規模（CINV、PONV、動揺病、妊娠、その他）
・吐き気・嘔吐治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・吐き気・嘔吐治療の販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Description

Scope of the Report:
The global Nausea And Vomiting Treatment market is valued at 4435.7 million USD in 2018 and is expected to reach 5646.8 million USD by the end of 2024, growing at a CAGR of 6.2% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Nausea And Vomiting Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Nausea And Vomiting Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Nausea And Vomiting Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Merck & Co. Inc.
Taiji group
Kyowa Kirin
Helsinn Group
Teva Pharmaceutical Industries Ltd.
Unimed Pharmaceuticals (AbbVie Inc.)
Heron Therapeutics
Qilu Pharma
Sanofi
Novartis
Atnahs Pharma UK Limited
Tesaro
Mylan
Duchesnay

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Other

Serotonin Receptor Antagonist had the biggest market share of 61% in 2018.

Market Segment by Applications, can be divided into
CINV
PONV
Motion Sickness
Pregnancy
Others

CINV is the greatest segment of Nausea And Vomiting Treatment application, with a share of 49% in 2018.

【レポートの目次】

Table of Contents

1 Nausea And Vomiting Treatment Market Overview
1.1 Product Overview and Scope of Nausea And Vomiting Treatment
1.2 Classification of Nausea And Vomiting Treatment by Types
1.2.1 Global Nausea And Vomiting Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Nausea And Vomiting Treatment Revenue Market Share by Types in 2018
1.2.3 Serotonin Receptor Antagonist
1.2.4 Neurokinin NK1 Receptor Antagonist
1.2.5 Other
1.3 Global Nausea And Vomiting Treatment Market by Application
1.3.1 Global Nausea And Vomiting Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 CINV
1.3.3 PONV
1.3.4 Motion Sickness
1.3.5 Pregnancy
1.3.6 Others
1.4 Global Nausea And Vomiting Treatment Market by Regions
1.4.1 Global Nausea And Vomiting Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Nausea And Vomiting Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Nausea And Vomiting Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nausea And Vomiting Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Nausea And Vomiting Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nausea And Vomiting Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Nausea And Vomiting Treatment (2014-2024)
2 Company Profiles
2.1 Merck & Co. Inc.
2.1.1 Business Overview
2.1.2 Nausea And Vomiting Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Taiji group
2.2.1 Business Overview
2.2.2 Nausea And Vomiting Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Kyowa Kirin
2.3.1 Business Overview
2.3.2 Nausea And Vomiting Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Helsinn Group
2.4.1 Business Overview
2.4.2 Nausea And Vomiting Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva Pharmaceutical Industries Ltd.
2.5.1 Business Overview
2.5.2 Nausea And Vomiting Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Unimed Pharmaceuticals (AbbVie Inc.)
2.6.1 Business Overview
2.6.2 Nausea And Vomiting Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Heron Therapeutics
2.7.1 Business Overview
2.7.2 Nausea And Vomiting Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Qilu Pharma
2.8.1 Business Overview
2.8.2 Nausea And Vomiting Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Nausea And Vomiting Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Novartis
2.10.1 Business Overview
2.10.2 Nausea And Vomiting Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Atnahs Pharma UK Limited
2.11.1 Business Overview
2.11.2 Nausea And Vomiting Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.12 Tesaro
2.12.1 Business Overview
2.12.2 Nausea And Vomiting Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Tesaro Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.13 Mylan
2.13.1 Business Overview
2.13.2 Nausea And Vomiting Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.14 Duchesnay
2.14.1 Business Overview
2.14.2 Nausea And Vomiting Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Nausea And Vomiting Treatment Market Competition, by Players
3.1 Global Nausea And Vomiting Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Nausea And Vomiting Treatment Players Market Share
3.2.2 Top 10 Nausea And Vomiting Treatment Players Market Share
3.3 Market Competition Trend
4 Global Nausea And Vomiting Treatment Market Size by Regions
4.1 Global Nausea And Vomiting Treatment Revenue and Market Share by Regions
4.2 North America Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
5 North America Nausea And Vomiting Treatment Revenue by Countries
5.1 North America Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
5.2 USA Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
6 Europe Nausea And Vomiting Treatment Revenue by Countries
6.1 Europe Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
6.2 Germany Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
6.4 France Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Nausea And Vomiting Treatment Revenue by Countries
7.1 Asia-Pacific Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
7.2 China Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
7.5 India Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
8 South America Nausea And Vomiting Treatment Revenue by Countries
8.1 South America Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
8.2 Brazil Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Nausea And Vomiting Treatment by Countries
9.1 Middle East and Africa Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
10 Global Nausea And Vomiting Treatment Market Segment by Type
10.1 Global Nausea And Vomiting Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Nausea And Vomiting Treatment Market Forecast by Type (2019-2024)
10.3 Serotonin Receptor Antagonist Revenue Growth Rate (2014-2024)
10.4 Neurokinin NK1 Receptor Antagonist Revenue Growth Rate (2014-2024)
10.5 Other Revenue Growth Rate (2014-2024)
11 Global Nausea And Vomiting Treatment Market Segment by Application
11.1 Global Nausea And Vomiting Treatment Revenue Market Share by Application (2014-2019)
11.2 Nausea And Vomiting Treatment Market Forecast by Application (2019-2024)
11.3 CINV Revenue Growth (2014-2019)
11.4 PONV Revenue Growth (2014-2019)
11.5 Motion Sickness Revenue Growth (2014-2019)
11.6 Pregnancy Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Nausea And Vomiting Treatment Market Size Forecast (2019-2024)
12.1 Global Nausea And Vomiting Treatment Market Size Forecast (2019-2024)
12.2 Global Nausea And Vomiting Treatment Market Forecast by Regions (2019-2024)
12.3 North America Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
12.6 South America Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Nausea And Vomiting Treatment Picture
Table Product Specifications of Nausea And Vomiting Treatment
Table Global Nausea And Vomiting Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Nausea And Vomiting Treatment Revenue Market Share by Types in 2018
Figure Serotonin Receptor Antagonist Picture
Figure Neurokinin NK1 Receptor Antagonist Picture
Figure Other Picture
Table Global Nausea And Vomiting Treatment Revenue (Million USD) by Application (2014-2024)
Figure Nausea And Vomiting Treatment Revenue Market Share by Applications in 2018
Figure CINV Picture
Figure PONV Picture
Figure Motion Sickness Picture
Figure Pregnancy Picture
Figure Others Picture
Table Global Market Nausea And Vomiting Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Inc. Nausea And Vomiting Treatment Type and Applications
Table Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Taiji group Basic Information, Manufacturing Base and Competitors
Table Taiji group Nausea And Vomiting Treatment Type and Applications
Table Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Kyowa Kirin Basic Information, Manufacturing Base and Competitors
Table Kyowa Kirin Nausea And Vomiting Treatment Type and Applications
Table Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Helsinn Group Basic Information, Manufacturing Base and Competitors
Table Helsinn Group Nausea And Vomiting Treatment Type and Applications
Table Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Type and Applications
Table Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Unimed Pharmaceuticals (AbbVie Inc.) Basic Information, Manufacturing Base and Competitors
Table Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Type and Applications
Table Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table Heron Therapeutics Nausea And Vomiting Treatment Type and Applications
Table Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Qilu Pharma Basic Information, Manufacturing Base and Competitors
Table Qilu Pharma Nausea And Vomiting Treatment Type and Applications
Table Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Nausea And Vomiting Treatment Type and Applications
Table Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Nausea And Vomiting Treatment Type and Applications
Table Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Atnahs Pharma UK Limited Basic Information, Manufacturing Base and Competitors
Table Atnahs Pharma UK Limited Nausea And Vomiting Treatment Type and Applications
Table Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Tesaro Basic Information, Manufacturing Base and Competitors
Table Tesaro Nausea And Vomiting Treatment Type and Applications
Table Tesaro Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Nausea And Vomiting Treatment Type and Applications
Table Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Duchesnay Basic Information, Manufacturing Base and Competitors
Table Duchesnay Nausea And Vomiting Treatment Type and Applications
Table Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Nausea And Vomiting Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Nausea And Vomiting Treatment Revenue Share by Players (2014-2019)
Figure Global Nausea And Vomiting Treatment Revenue Share by Players in 2017
Figure Global Nausea And Vomiting Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Nausea And Vomiting Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Nausea And Vomiting Treatment Revenue Market Share in 2018
Figure Global Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Nausea And Vomiting Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Nausea And Vomiting Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Nausea And Vomiting Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Nausea And Vomiting Treatment Revenue Market Share by Regions in 2018
Figure North America Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure South America Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Table North America Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
Table North America Nausea And Vomiting Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Nausea And Vomiting Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Nausea And Vomiting Treatment Revenue Market Share by Countries in 2018
Figure USA Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Table Europe Nausea And Vomiting Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Nausea And Vomiting Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Nausea And Vomiting Treatment Revenue Market Share by Countries in 2018
Figure Germany Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure UK Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure France Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Nausea And Vomiting Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Nausea And Vomiting Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Nausea And Vomiting Treatment Revenue Market Share by Countries in 2018
Figure China Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure India Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Table South America Nausea And Vomiting Treatment Revenue by Countries (2014-2019)
Table South America Nausea And Vomiting Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Nausea And Vomiting Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Nausea And Vomiting Treatment Revenue Market Share by Countries in 2018
Figure Brazil Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Nausea And Vomiting Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Nausea And Vomiting Treatment Revenue and Growth Rate (2014-2019)
Table Global Nausea And Vomiting Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Nausea And Vomiting Treatment Revenue Share by Type (2014-2019)
Figure Global Nausea And Vomiting Treatment Revenue Share by Type (2014-2019)
Figure Global Nausea And Vomiting Treatment Revenue Share by Type in 2018
Table Global Nausea And Vomiting Treatment Revenue Forecast by Type (2019-2024)
Figure Global Nausea And Vomiting Treatment Market Share Forecast by Type (2019-2024)
Figure Global Serotonin Receptor Antagonist Revenue Growth Rate (2014-2019)
Figure Global Neurokinin NK1 Receptor Antagonist Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Nausea And Vomiting Treatment Revenue by Application (2014-2019)
Table Global Nausea And Vomiting Treatment Revenue Share by Application (2014-2019)
Figure Global Nausea And Vomiting Treatment Revenue Share by Application (2014-2019)
Figure Global Nausea And Vomiting Treatment Revenue Share by Application in 2018
Table Global Nausea And Vomiting Treatment Revenue Forecast by Application (2019-2024)
Figure Global Nausea And Vomiting Treatment Market Share Forecast by Application (2019-2024)
Figure Global CINV Revenue Growth Rate (2014-2019)
Figure Global PONV Revenue Growth Rate (2014-2019)
Figure Global Motion Sickness Revenue Growth Rate (2014-2019)
Figure Global Pregnancy Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Nausea And Vomiting Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Nausea And Vomiting Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Nausea And Vomiting Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
Figure Europe Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
Figure South America Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Nausea And Vomiting Treatment Revenue Market Forecast (2019-2024)

【掲載企業】

Merck & Co. Inc.、 Taiji group、 Kyowa Kirin、 Helsinn Group、 Teva Pharmaceutical Industries Ltd.、 Unimed Pharmaceuticals (AbbVie Inc.)、 Heron Therapeutics、 Qilu Pharma、 Sanofi、 Novartis、 Atnahs Pharma UK Limited、 Tesaro、 Mylan、 Duchesnay、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 吐き気・嘔吐治療の世界市場2019(Global Nausea And Vomiting Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp